The backer behind Facebook-owned Bloomsbury AI is raising up to £100 million to find another DeepMind

Advertisement
The backer behind Facebook-owned Bloomsbury AI is raising up to £100 million to find another DeepMind

Google DeepMind CEO Demis Hassabis

Google DeepMind

Google DeepMind CEO Demis Hassabis, who met his cofounder Shane Legg at UCL.

Advertisement
  • UCL's spinout fund is raising up to £100 million ($126 million) to commercialise research and technology coming out of its departments.
  • The idea is to create future success stories such as DeepMind, whose founders met at UCL and went on to sell the artificial intelligence company to Googe.
  • The first UCL technology fund backed startups like Bloomsbury AI, which was acquired by Facebook in 2018.
  • Albion Ventures, which helps manage the fund, said UCL was on track to create several British unicorns.

A university spinout fund that backed Bloomsbury AI, the artificial intelligence startup acquired by Facebook earlier this year, is looking to raise a second fund of between £75 million to £100 million ($126 million).

University College London is raising the tranche of money to develop its academic research into commercial companies, akin to Oxford or Cambridge. UCL raised £50 million for its first fund in 2016, and hopes to double the amount for its second.

Complimentary Tech Event
Transform talent with learning that works
Capability development is critical for businesses who want to push the envelope of innovation.Discover how business leaders are strategizing around building talent capabilities and empowering employee transformation.Know More

Both funds are managed by UK venture capital firm Albion Ventures and UCL's commercialisation arm, UCLB.

Andrew Elder, partner at Albion Ventures, told Business Insider that the university was on track to produce several unicorns.

Advertisement

Google-owned artificial intelligence company DeepMind was spun out of UCL's computer science unit, before it was acquired for £400 million ($650 million). A gene therapy startup backed by UCL's first technology fund, MeiraGTX, raised $75 million (£60 million) on the Nasdaq when it floated in June. Biotech firm Orchard Therapeutics raised $225 million (£173 million) through an IPO in November. Bloomsbury AI was bought by Facebook around July.

"It has been a significantly positive return so far, especially relative to a fund of this type and stage," said Elder.

At least one potential fund backer has dropped out thanks to Brexit. The European Investment Fund, which puts money into European investment firms, is unlikely to invest. It had committed £24.75 million to the first UCL technology fund, according to a Financial Times report at the time.

The UK government's equivalent, the British Business Bank, is lined up as a replacement investor. The EIF froze its investments into the UK while it evaluated the risks around Brexit.

Other backers include financial institutions, sovereign wealth funds, high net worth individuals, and corporates.

Advertisement

Dr Anna Lane, executive director at UCLB, said in a statement: "The fund has been successful because of its unique investment approach and clear, transparent and supportive processes. We are proud that its early success has meant we need to consider another fund."

{{}}